Young-Lady-inhales-with-eFlow-rapid-and-uses-eBase-Controller.jpg

eFlow®rapid Nebuliser System

With newly designed eBase® Controller for better handling and more mobility

The eFlow^®rapid nebuliser system with new eBase Controller is suitable for the treatment of a wide range of diseases of the lower airways. It stands for efficient, safe and fast inhalation treatment, combined with even more advantages:

Flexible use thanks to handy controller design, battery pack and light, small and silent device.
Individuality due to setting options that allow to adjust the controller lights and sounds according to individual requirements
Time-saving - immediate switch-off at the end of inhalation and short nebulisation times [1] thanks to eFlow^® Technology

More about the eFlow^®rapid nebuliser system

Are you using the blue eBase Controller? Please click here!

_{^[1] Naehrig S et al. Eur J Med Res 2011; 16(2): 63-6}

Item No.: WE: 178G1100 – OE: 178G1102

Using the eFlow®rapid correctly

Click on the video links below to find out more about the topics listed. Please always follow the respective instructions for use.

_{Please note: When you click on a link, you leave our homepage and open a YouTube page. For more information, please see our Privacy Policy.}

All information about eFlow®rapid nebuliser system

Download: Instructions for use, product information

Instructions for use

Instructions for use eFlow®rapid nebuliser system Western Europe

Instructions for use
178D1200-C 2023-09

49.09 MB Download PDF

Instructions for use

Instructions for use eFlow®rapid nebuliser system Eastern Europe

Instructions for use
178D1203-B 2023-09

55.04 MB Download PDF

Instructions for use

easycare Cleaning aid for aerosol head

Instructions for use
078D1014-F-2022-11

10.63 MB Download PDF

Aerosol characteristics of the eFlow^®rapid nebuliser system

MMAD^a):	4,6 µm
Respirable Fraction^a) < 5 µm:	55 %
Aerosol Output Rate^b):	0,5 g/min

Aerosol data according to ISO 27427; nebulised medium: Salbutamol 2.5 ml. Measured values may vary depending on the medication used. Recommended fill volume: see package leaflet for the medication.

^a) Measurement with Next Generation Pharmaceutical Impactor (NGI) at 23 °C and 50% relative humidity. Inspiratory flow: 15 l/min

^b) Measurement with breathing simulator at 23 °C and 50 % relative humidity. 500 ml breathing volume, breathing frequency 15 cycles/minute, sinusoidal breathing pattern, inhalation/exhalation ratio 1:1 (with adults, may vary in children).

For more technical information please see the Instructions for use.

Electromagnetic compatibility Guidance

Electromagnetic compatibility - Guidance and manufacturer's declaration IEC 60601-1-2

228.53 KB Download PDF